The importance of versican in breast cancer pathogenesis is well illustrated in a recent study by Kischel et al. These authors demonstrate that all known versican isoforms as well as new alternatively spliced versican isoform, named V4, were significantly overexpressed in the malignant lesions [50]. This evidence concerns the gene VCAN and breast carcinoma.